-
300% rally in 14 months! This Aditya Birla Group firm to shine further post best quarterly performance
Shares of the metals major have rallied 343% to Rs 389.85 on May 21 from the low of Rs 87.95, scaled on March 23 last year
-
Top portfolio managers delivered over 100% returns with these stocks; do you own any?
Equirus Long Horizon Fund, AccuraCap PicoPower, Centrum Microcap and SageOne Investment Core Portfolio stood among other PMS schemes which delivered 100%-127% return to investors.
-
State Bank of India soars ahead of Q4 results
State Bank of India is quoting at Rs 389.5, up 1.29% on the day as on 12:49 IST on the NSE. The stock is up 158.2% in last one year as compared to a 66.98% spurt in NIFTY.
-
Portfolio 2030: CLSA suggests these Indian stocks for Gen Z
the portfolio has four stocks — Asian Paints, FMCG players Dabur and Hindustan Unilever and QSR major Jubilant FoodWorks
-
Monsoon stocks: These eight companies are likely to benefit from normal rains
In India, around 58% of employment comes from agriculture and contributes almost 18% to the country's gross domestic product
-
Financial crunch? Think twice before taking loan against shares
Interest rates charged and the other charges like loan processing and interest in delayed payments are quite high
-
This stock turned Rs 10,000 into Rs 8 lakh in 10 years
Shares of the company climbed to Rs 1,813.90 on May 19, 2021 from Rs 21.26 on the same date in 2011
-
These five key changes can make your investment portfolio Covid-proof
Concerns over Covid-19 and ongoing state-wise restrictions have turned the equity investors cautious on Dalal Street. However, analysts continued to retain their bullish view on the domestic equity market on hopes of rapid improvement as seen in Britain and Spain, where a similar high infection growth rate was seen. An analysis by Antique Stock Broking […]
-
LIC has raised stake in this pharma major amid Covid 2.0; should you invest?
The company recently informed bourses that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly for expanding access to Lilly’s drug, baricitinib in India
-
Should you invest in Tata Motors after over Rs 7,500 crore loss in Q4?
Shares of the company traded 4.44% down at Rs 317.60 at around 10 am (IST). On the other hand, the benchmark BSE Sensex was up 28 points, or 0.06%, at 50,221 at around the same time.
